Boston Scientific said its first-quarter net income roughly doubled as demand continued to grow worldwide for its stents, ...

Boston Scientific (NYSE:BSX) today reported first-quarter financial results that came in ahead of the Wall Street forecast.

CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including ...

On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech ...

Analysts have trimmed their fair value estimate for Boston Scientific from US$100.31 to US$95.75, a reset that anchors the ...

Despite Boston’s Q1 performance denoting a YoY rise of 11.2%, the company has trimmed its full-year growth outlook by 2% at the top-end.

April 22 () - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a ...

Author Rachel Zoffness breaks down why we have chronic pain and how science shows that it’s all in our head ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. The ...

AI has already proved itself a valuable scientific tool. Could it take on a more central role in the research process?